<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Diehl C</submitter><funding>LOEWE program state of Hesse</funding><funding>Gordon and Betty Moore Foundation</funding><funding>Max-Planck-Gesellschaft</funding><pagination>168-175</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9889269</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(2)</volume><pubmed_abstract>Anaplerosis is an essential feature of metabolism that allows the continuous operation of natural metabolic networks, such as the citric acid cycle, by constantly replenishing drained intermediates. However, this concept has not been applied to synthetic in vitro metabolic networks, thus far. Here we used anaplerotic strategies to directly access the core sequence of the CETCH cycle, a new-to-nature in vitro CO&lt;sub>2&lt;/sub>-fixation pathway that features several C&lt;sub>3&lt;/sub>-C&lt;sub>5&lt;/sub> biosynthetic precursors. We drafted four different anaplerotic modules that use CO&lt;sub>2&lt;/sub> to replenish the CETCH cycle's intermediates and validated our designs by producing 6-deoxyerythronolide B (6-DEB), the C&lt;sub>21&lt;/sub>-macrolide backbone of erythromycin. Our best design allowed the carbon-posit</pubmed_abstract><journal>Nature chemical biology</journal><pubmed_title>Synthetic anaplerotic modules for the direct synthesis of complex molecules from CO&lt;sub>2&lt;/sub>.</pubmed_title><pmcid>PMC9889269</pmcid><funding_grant_id>GBMF10652</funding_grant_id><pubmed_authors>Erb TJ</pubmed_authors><pubmed_authors>Diehl C</pubmed_authors><pubmed_authors>Paczia N</pubmed_authors><pubmed_authors>Gerlinger PD</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synthetic anaplerotic modules for the direct synthesis of complex molecules from CO&lt;sub>2&lt;/sub>.</name><description>Anaplerosis is an essential feature of metabolism that allows the continuous operation of natural metabolic networks, such as the citric acid cycle, by constantly replenishing drained intermediates. However, this concept has not been applied to synthetic in vitro metabolic networks, thus far. Here we used anaplerotic strategies to directly access the core sequence of the CETCH cycle, a new-to-nature in vitro CO&lt;sub>2&lt;/sub>-fixation pathway that features several C&lt;sub>3&lt;/sub>-C&lt;sub>5&lt;/sub> biosynthetic precursors. We drafted four different anaplerotic modules that use CO&lt;sub>2&lt;/sub> to replenish the CETCH cycle's intermediates and validated our designs by producing 6-deoxyerythronolide B (6-DEB), the C&lt;sub>21&lt;/sub>-macrolide backbone of erythromycin. Our best design allowed the carbon-posit</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-04-21T22:52:19.782Z</modification><creation>2025-04-05T18:57:23.084Z</creation></dates><accession>S-EPMC9889269</accession><cross_references><pubmed>36470994</pubmed><doi>10.1038/s41589-022-01179-0</doi></cross_references></HashMap>